Physionic

Physionic

Creator
0 followers

Research-focused explainers on metabolism, nutrition, and supplement mechanisms.

The Most Impressive Anti-Aging Supplement
VideoMay 12, 2026

The Most Impressive Anti-Aging Supplement

The video spotlights Glynac, a blend of the amino acid glycine and N‑acetylcysteine, as perhaps the most comprehensive anti‑aging supplement on the market. Originating from mouse studies that suggested lifespan extension, the formula has migrated into human research. Multiple randomized, placebo‑controlled...

By Physionic
Eye Supplement Also Protects Against Cancer
VideoApr 29, 2026

Eye Supplement Also Protects Against Cancer

The video examines zeaxanthin, a carotenoid found in a popular eye‑health supplement, and its emerging profile as a possible adjunct in cancer therapy. A recent pre‑clinical study showed that zeaxanthin can amplify the effect of immunotherapy drugs, while a series of...

By Physionic
1 Year of Lycopene: Reversing Arterial Plaque
VideoApr 22, 2026

1 Year of Lycopene: Reversing Arterial Plaque

The video examines lycopene—a tomato‑derived antioxidant—and its potential to reverse arterial plaque buildup. The presenter reviews multiple observational studies that consistently report an inverse relationship between circulating lycopene levels and plaque prevalence, suggesting a protective trend across diverse populations. Key data...

By Physionic
Eating This Reduces Visceral Fat
VideoApr 15, 2026

Eating This Reduces Visceral Fat

The video highlights resistant starches, specifically RS2, as a potent dietary tool for reducing visceral fat. Citing large‑scale Nature Metabolism and Cell Metabolism trials, the presenter notes that a daily dose of 40 g of RS2 produced statistically significant visceral fat...

By Physionic
A Supplement that ACTUALLY Prevents Cancer
VideoMar 14, 2026

A Supplement that ACTUALLY Prevents Cancer

Berberine, a plant‑derived alkaloid, has emerged as the focus of a recent clinical investigation into colorectal cancer prevention. The randomized, placebo‑controlled trial enrolled participants at elevated risk and administered 600 mg of berberine daily, divided into two doses, over a two‑year...

By Physionic
Physionic | Pulse